Ann & Robert H Lurie Children's Hospital of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Ann & Robert H Lurie Children's Hospital of Chicago sits in the top decile of US sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count).
Ann & Robert H Lurie Children's Hospital of Chicago: 159 sponsored US clinical trials, 31 recruiting.
Ann & Robert H Lurie Children's Hospital of Chicago sponsors 159 registered US clinical trials on ClinicalTrials.gov, 31 of them currently recruiting, and 103 completed. 5 of these trials are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Eosinophilic Esophagitis, with 6 trials.
Top-decile sponsor footprint
Ann & Robert H Lurie Children's Hospital of Chicago ranks in the top decile of sponsors by registered trial count (#185 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
103 of 112 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (92.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
159 total, page 1 of 4
Supporting Caregivers Following Mental Health Emergency Department Visits
NCT07411300
Comparing Antibiotic Treatment Strategies for Children With Pneumonia in Outpatient Settings: (STAMPP)
NCT06986148
Impact of Hospital to Home: Optimizing Preterm Infant Environment for Surgical Neonates and Their Parents (H-HOPE)
NCT07372898
Our Voices Matter: Intervention for Depression in Youth
NCT07216326
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
NCT06712875
Technology-Enhanced Asthma Care in Children at Clinic and Home Study
NCT06820593
Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients
NCT06395636
CCHS Secure Health-hub Advancing Research Efforts (CCHS SHARE)
NCT06554275
Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
NCT06430684
A Hybrid Effectiveness-implementation Trial to Reduce Diabetes Distress in Teenagers
NCT06709755
Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
NCT06235125
The Grief Navigation Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death
NCT06136260
Adaptive Mechanisms Responsible for Weight Change in Youth With Obesity
NCT05125822
Myopia Control: a Comparison Study Between Atropine and MiSight
NCT05815784
Distal Radius Interventions for Fracture Treatment
NCT05131685
Neural Prediction to Enhance Language
NCT05962359
Mastery Learning in Communication Skills
NCT05979090
Post-Vent, the Sequelae: Personalized Prognostic Modeling for Consequences of Neonatal Intermittent Hypoxemia in Preterm Infants at Pre-School Age
NCT05336890
Cast or Operation for Medial Epicondyle Fracture Treatment in Children
NCT05131672
Comparative Effectiveness of Palliative Surgery Versus Additional Anti-Seizure Medications for Lennox-Gastaut Syndrome
NCT05374824
A Novel Probiotic-antibiotic Combination to Prevent Recurrent Urinary Tract Infections
NCT06149676
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
NCT04943848
The Pediatric ALL Evaluation and Trial
NCT04825587
Families Filming Infants Learning Movement
NCT06278961
Eosinophilic Gastrointestinal Disorders Registry
NCT05199532
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
NCT04688411
Perinatal Transmission of MDR Bacteria
NCT06148480
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
NCT05120518
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
NCT04723654
Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age
NCT04118712
The Treatment of Type I Open Fractures in Pediatrics
NCT00870064
Testing "SupporT for ADHD and Related Treatment" (START) for Families of Children With ADHD
NCT05796427
Midwest TXTXT Scale up of an Evidence-Based Intervention to Promote HIV Medication Adherence
NCT05783297
The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD.
NCT04691323
Partners in Caring for Anxious Youth
NCT04598230
Intervention to Reduce Early (Peanut) Allergy in Children
NCT04604431
Local Version of the Multi-center PREVENT Study Evaluating Cardio-respiratory Instability in Premature Infants
NCT03655639
Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
NCT05309590
Prophylactic Antibiotics or Placebo After Hypospadias Repair
NCT02096159
Cow's Milk Elimination for Treatment of Eosinophilic Esophagitis
NCT05083156
Prospective Database for Eosinophilic Esophagitis (EoE) of Pediatric Population
NCT05176249
A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
NCT05176262
Inflammatory Mediators as Potential Non-Invasive Biomarkers in Subjects With Eosinophilic Esophagitis
NCT03822325
Reducing Disparities in Knee Arthroscopy for Adolescents
NCT07580625
Caring Contacts Via Text Message for Suicidal Adolescents After Emergency Department Discharge
NCT07043764
Pre-emptive Anakinra for Cytokine Event Reduction
NCT06703216
Pain After Strabismus Surgery
NCT06689943
Implementation of Project YES in Ambulatory Adolescent & Young Adult Medicine
NCT06359951
Advancing the Science of Pediatric Interstage Home Monitoring
NCT06547268
CEDARS Intervention: A Coping, Emotional Development, & Stress Reduction Intervention
NCT04958694
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 13 |
| Phase 2 | 16 |
| Phase 3 | 2 |
| Phase 4 | 3 |
What is open in the Ann & Robert H Lurie Children's Hospital of Chicago pipeline
31 recruiting of 159 indexed (19% open); 103 completed (65%).
Phase mix: 5 late (III/IV) vs 29 early (I/II) (early-phase heavy).
Top condition: Eosinophilic Esophagitis (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Ann & Robert H Lurie Children's Hospital of Chicago: open-pipeline peers nationwide
Peers matched on 159 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Ann & Robert H Lurie Children's Hospital of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 159 trials (± recruiting share)
- Galderma R&D · 158 trials · 4% recruiting
- Pfizer's Upjohn has merged with Mylan to form Viatris · 158 trials · 0% recruiting
- University of South Carolina · 157 trials · 19% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Scripps Translational Science Institute · 20% recruiting · 41 trials
- UCB Biopharma SRL · 20% recruiting · 82 trials
- University of Texas Southwestern Medical Center · 19% recruiting · 837 trials
- The University of Texas Health Science Center, Houston · 20% recruiting · 732 trials
Related
What to do with this Ann & Robert H Lurie Children's Hospital of Chicago page
159 registered trials is a research-attention snapshot, not an endorsement of Ann & Robert H Lurie Children's Hospital of Chicago or any single study.
- 31 of Ann & Robert H Lurie Children's Hospital of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Eosinophilic Esophagitis is the condition Ann & Robert H Lurie Children's Hospital of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Eosinophilic Esophagitis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Ann & Robert H Lurie Children's Hospital of Chicago pipeline card: 159 registered trials from official public datasets.Report a data error.